fda warning letters compounded semaglutide september 2025 COMES FOR NOVO DRAMA. #medicine #wellness #news #life #hospital U.S. FDA sends drug advertising

Elevations in lipase and amylase levels are commonly seen, often without clinical signs of pancreatitis, making interpretation challenging

The addition of B12 does not boost weight loss, but may help combat the side effects of semaglutide, such as lethargy and dizziness, by promoting metabolism and increasing the availability of usable energy

Your eligibility for Semaglutide depends on several factors, including Type 2 diabetes or obesity, overall health status, and specific criteria outlined by your healthcare professionals

These medications work by mimicking the effects of the GLP-1 hormone, which helps regulate blood sugar levels, promotes satiety, and can lead to weight loss

The current thinking is that in many people with obesity, that signal exists but isn't getting through loudly enough, a kind of appetite dysregulation

At our The Woodlands clinic, providers review medical history, lab results, and individual health goals before recommending treatment